Trial intelligence / Profile preview

Aspirin for prevention of preeclampsia

IRCT20220410054469N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jun 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of aspirin in preeclampsia, sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2022; status: completed.

02

Drugs

aspirin
03

Conditions

preeclampsia

Beyond the preview

Go deeper on IRCT20220410054469N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220410054469N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call